These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 3407439)

  • 21. Dexamethasone suppression test and cortisol circadian rhythm in primary degenerative dementia.
    Raskind M; Peskind E; Rivard MF; Veith R; Barnes R
    Am J Psychiatry; 1982 Nov; 139(11):1468-71. PubMed ID: 7137397
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The dexamethasone suppression test in dementia.
    Magni G; Schifano F; De Leo D; Zangaglia O
    Ital J Neurol Sci; 1987 Apr; 8(2):125-8. PubMed ID: 3597052
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of adolescents with major depression: implications of the DST and the melancholic clinical subtype.
    Robbins DR; Alessi NE; Colfer MV
    J Affect Disord; 1989; 17(2):99-104. PubMed ID: 2527896
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Results of dexamethasone suppression test in early Alzheimer dementia.
    De Leo D; Schifano F; Magni G
    Eur Arch Psychiatry Neurol Sci; 1988; 238(1):19-21. PubMed ID: 3215214
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The dexamethasone suppression test: its relationship to diagnoses, severity of depression and response to treatment.
    Dratcu L; Calil HM
    Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13(1-2):99-117. PubMed ID: 2748868
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The dexamethasone suppression test in patients with primary obsessive-compulsive disorder.
    Insel TR; Kalin NH; Guttmacher LB; Cohen RM; Murphy DL
    Psychiatry Res; 1982 Apr; 6(2):153-60. PubMed ID: 6953457
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dexamethasone suppression test and treatment response.
    Gitlin MJ; Gwirtsman H; Fairbanks L; Sternbach HA; Cedars PI; Gerner RH
    J Clin Psychiatry; 1984 Sep; 45(9):387-9. PubMed ID: 6469923
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cortisol, ACTH, and beta-endorphin after dexamethasone administration in Parkinson's dementia.
    Rabey JM; Scharf M; Oberman Z; Zohar M; Graff E
    Biol Psychiatry; 1990 Mar; 27(6):581-91. PubMed ID: 2157505
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Normalisation of the dexamethasone suppression test: a correlate of clinical improvement in primary depressives.
    Bowie PC; Beaini AY
    Br J Psychiatry; 1985 Jul; 147():30-5. PubMed ID: 4063596
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Persistent cortisol non-suppression after clinical recovery predicts symptomatic relapse in unipolar depression.
    Charles GA; Schittecatte M; Rush AJ; Panzer M; Wilmotte J
    J Affect Disord; 1989; 17(3):271-8. PubMed ID: 2529296
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dexamethasone suppression test in masked depression.
    Rihmer Z; Szádoczky E; Arató M
    J Affect Disord; 1983 Nov; 5(4):293-6. PubMed ID: 6229560
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Depression, negative and positive symptoms, and the DST in schizophrenia.
    Minas IH; Jackson HJ; Joshua SD; Burgess PM
    Schizophr Res; 1990; 3(5-6):321-7. PubMed ID: 2282337
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The dexamethasone suppression test (DST) in predicting response to desipramine and amitriptyline in depressed outpatients.
    Peselow ED; Goldring N; Stanley M; Barouche F; Fieve RR
    Int Clin Psychopharmacol; 1986 Jan; 1(1):17-23. PubMed ID: 3549869
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dexamethasone suppression test and mood response to methylphenidate in primary depression.
    Brown P; Brawley P
    Am J Psychiatry; 1983 Aug; 140(8):990-3. PubMed ID: 6346911
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serial dexamethasone suppression test results during antidepressant therapy: relationship to diagnosis and clinical change.
    Coryell W; Smith R; Cook B; Moucharafieh S; Dunner F; House D
    Psychiatry Res; 1983 Nov; 10(3):165-74. PubMed ID: 6582524
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical, magnetic resonance imaging and endocrinological differences between delusional and non-delusional depression in the elderly.
    O'Brien JT; Ames D; Schweitzer I; Desmond P; Coleman P; Tress B
    Int J Geriatr Psychiatry; 1997 Feb; 12(2):211-8. PubMed ID: 9097214
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dexamethasone suppression tests in antidepressant treatment of melancholia. The process of normalization and test-retest reproducibility.
    Greden JF; Gardner R; King D; Grunhaus L; Carroll BJ; Kronfol Z
    Arch Gen Psychiatry; 1983 May; 40(5):493-500. PubMed ID: 6340634
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of the introduction of the dexamethasone suppression test on diagnosis and treatment of depression by psychiatrists.
    Schrader GD; Durbridge TC
    Aust N Z J Psychiatry; 1983 Dec; 17(4):350-3. PubMed ID: 6581793
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypothalamic-pituitary-adrenocortical function in geriatric depression: diagnostic and treatment implications.
    Georgotas A; Stokes PE; Krakowski M; Fanelli C; Cooper T
    Biol Psychiatry; 1984 May; 19(5):685-93. PubMed ID: 6733180
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Affective disorders in the elderly: diagnostic and research considerations.
    Georgotas A
    Age Ageing; 1983 Feb; 12(1):1-10. PubMed ID: 6846086
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.